Stay updated on Venetoclax with Azacitidine post-SCT in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax with Azacitidine post-SCT in AML Clinical Trial page.

Latest updates to the Venetoclax with Azacitidine post-SCT in AML Clinical Trial page
- Check6 days agoChange DetectedThe page footer now displays Revision: v3.5.4, reflecting a minor platform update to the history page. This change does not modify study data or how users interact with the page.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe history now shows a 'Results Submitted' entry, indicating that results have been submitted. The page revision has been updated to v3.5.3, replacing the previous v3.5.2 revision.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision history updated: added v3.5.2 and removed v3.5.0.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded Revision: v3.5.0 and deleted Revision: v3.4.3 from the history.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page history.SummaryDifference0.0%

- Check99 days agoChange DetectedThe page history shows a new revision tag (v3.4.2) added and the prior government funding notices removed; these are minor site-wide changes and do not affect trial data or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Venetoclax with Azacitidine post-SCT in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax with Azacitidine post-SCT in AML Clinical Trial page.